1.15|0.72|7.46
委比:--
委差:--
卖五 | -- | -- |
卖四 | -- | -- |
卖三 | -- | -- |
卖二 | -- | -- |
卖一 | -- | -- |
买一 | -- | -- |
买二 | -- | -- |
买三 | -- | -- |
买四 | -- | -- |
买五 | -- | -- |
总流入:--万元
总流出:--万元
净 额:--万元
近5日内该股资金总体呈流入状态,高于行业平均水平,5日共流入2200.47万元。
近5日内该股资金总体呈流入状态,高于行业平均水平,5日共流入2200.63万元。
据统计,近10日内主力筹码较分散,呈低度控盘状态。
公司简介
- 所属地域:
- 湖北省
- 涉及概念:
- 辅助生殖,融资融券,生物医药
- 主营业务:
- 经营分析
- 医药科技开发和技术服务;医药原料药及中间体生...
- 上市日期:
- 2021-04-09
- 每股净资产:
- 7.46元
- 每股收益:
- 0.03元
- 净利润:
- 0.04亿元
- 净利润增长率:
- -11.86%
- 营业收入:
- 1.22亿元
- 每股现金流:
- -0.21元
- 每股公积金:
- 3.57元
- 每股未分配利润:
- 2.81元
- 总股本:
- 1.15亿
- 流通股:
- 0.72亿
单位:万元
{"year":[2024,2023,2022],"s03":[354.73,402.44,""],"s06":["",1747.2,""],"s09":["",2278.45,""],"s12":["",2300.5,4020.52]}
同行业市场表现排行
5.1
综合判断:5.1分
打败了49%的股票!
短期趋势:
强势上涨过程中,可逢低买进,暂不考虑做空。
长期趋势:
已有28家主力机构披露2023-12-31报告期持股数据,持仓量总计740.96万股,占流通A股12.54%
近期的平均成本为17.01元。该股资金方面受到市场关注,多方势头较强。该公司运营状况不佳,但多数机构认为该股有长期投资价值。 [诊断日期:2024年04月30日 16:56]
技术面诊股4.90
资金面诊股5.20
消息面诊股6.20
行业面诊股4.90
基本面诊股4.80
最近60个交易日,机构评级以增持为主,认为该股票有一定投资价值。
研究机构 |
评级日期 |
最新评级 |
上次评级 |
太平洋证券 |
2024-04-26 |
增持 |
增持 |
该股2024年每股收益与前一年相同,长期投资价值一般。
[{"date":"2020","yellowRectValue":"0.53","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.78","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.23","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.04","blueLineValue":"0.03","type":"YC"}]
查看历史大宗交易信息>>
交易日期 |
成交价(元) |
成交金额(万元) |
成交量(万股) |
溢价率 |
买入营业部 |
卖出营业部 |
2024-04-18 |
12.13 |
200.15 |
16.50 |
-16.29% |
中国银河证券股份有限公司襄阳证券营业部 |
太平洋证券股份有限公司襄阳朝阳路证券营业部 |
融资融券
查看历史融资融券信息>>
融资余额若长期增加时表示投资者心态偏向买方,市场人气旺盛属强势市场;反之则属弱势市场。
交易日期 |
融资余额(亿元) |
融资余额/流通市值 |
融资买入额(亿元) |
融券卖出量(万股) |
融券余量(万股) |
融券余额(万元) |
融资融券余额(亿元) |
2024-04-29 |
0.619
|
5.43%
|
0.013
|
0.17 |
0.68 |
10.83 |
0.620
|
2024-04-26 |
0.626
|
5.69%
|
0.024
|
0.04 |
0.61 |
9.36 |
0.627
|
2024-04-25 |
0.649
|
5.88%
|
0.065
|
0.13 |
0.77 |
11.87 |
0.651
|
2024-04-24 |
0.601
|
5.60%
|
0.016
|
0.10 |
0.64 |
9.58 |
0.602
|
2024-04-23 |
0.600
|
5.67%
|
0.006
|
0.00 |
0.54 |
7.98 |
0.601
|
2024-04-22 |
0.599
|
5.77%
|
0.011
|
0.00 |
0.79 |
11.44 |
0.600
|
2024-04-19 |
0.598
|
5.84%
|
0.003
|
0.02 |
0.79 |
11.29 |
0.599
|
2024-04-18 |
0.611
|
5.89%
|
0.005
|
0.00 |
0.77 |
11.16 |
0.612
|
2024-04-17 |
0.620
|
5.81%
|
0.010
|
0.00 |
0.77 |
11.47 |
0.621
|
2024-04-16 |
0.630
|
6.39%
|
0.011
|
0.00 |
0.80 |
11.00 |
0.631
|
|
百利天恒 |
普利制药 |
华特达因 |
共同药业 |
摊薄每股收益 |
12.48 |
0.93 |
0.72 |
0.03 |
行业排名 |
1 |
2 |
3 |
108 |
[["2024-03-31","354.73","0.03"],["2023-12-31","2300.50","0.20"],["2023-09-30","2278.45","0.20"],["2023-06-30","1747.20","0.15"],["2023-03-31","402.44","0.03"]]
[["\u767e\u5229\u5929\u6052","12.48"],["\u666e\u5229\u5236\u836f","0.93"],["\u534e\u7279\u8fbe\u56e0","0.72"],["\u5171\u540c\u836f\u4e1a","0.03"]]|107
300966
深证成指
399001
sz
1140
共同药业
[{"date":"20240401","item0":"2.97","item1":"3.44"},{"date":"20240402","item0":"-0.62","item1":"-1.43"},{"date":"20240403","item0":"-1.08","item1":"0.81"},{"date":"20240408","item0":"-1.81","item1":"-8.02"},{"date":"20240409","item0":"1.14","item1":"6.83"},{"date":"20240410","item0":"-2.06","item1":"-4.34"},{"date":"20240411","item0":"-0.44","item1":"-0.80"},{"date":"20240412","item0":"-1.08","item1":"0.62"},{"date":"20240415","item0":"1.85","item1":"-8.05"},{"date":"20240416","item0":"-1.97","item1":"-8.09"},{"date":"20240417","item0":"2.11","item1":"8.29"},{"date":"20240418","item0":"-0.55","item1":"-2.69"},{"date":"20240419","item0":"-1.76","item1":"-1.38"},{"date":"20240422","item0":"-0.32","item1":"1.33"},{"date":"20240423","item0":"0.15","item1":"2.00"},{"date":"20240424","item0":"0.70","item1":"1.35"},{"date":"20240425","item0":"-0.04","item1":"3.01"},{"date":"20240426","item0":"3.34","item1":"-0.52"},{"date":"20240429","item0":"3.50","item1":"3.78"},{"date":"20240430","item0":"-1.55","item1":"11.62"}]
||
您尚未登录,请登录后再添加自选股!